STOCK TITAN

[SCHEDULE 13G] Scienture Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Scoggin-affiliated investors report a small passive stake in Scienture Holdings Inc. The filing discloses that Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC and individuals Curtis Schenker and Craig Effron each beneficially own 150,000 shares of Scienture common stock, representing 0.01% of the 16,131,180 shares outstanding cited in the filing. The reporting persons state the holdings were not acquired to influence control of the issuer and identify the relationships among the entities: Scoggin GP LLC is the general partner of Scoggin Management LP, which manages Scoggin International Fund Ltd., and Messrs. Schenker and Effron are co-managing members. Exhibits include a joint filing agreement and an Item 8 statement.

Investitori legati a Scoggin dichiarano una piccola partecipazione passiva in Scienture Holdings Inc. La comunicazione indica che Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC e gli individui Curtis Schenker e Craig Effron possiedono ciascuno beneficiariamente 150.000 azioni ordinarie di Scienture, pari allo 0,01% delle 16.131.180 azioni in circolazione citate nel deposito. I soggetti segnalanti precisano che le partecipazioni non sono state acquisite per influenzare il controllo dell'emittente e descrivono i rapporti tra le entità: Scoggin GP LLC è il general partner di Scoggin Management LP, che gestisce Scoggin International Fund Ltd., mentre i signori Schenker ed Effron sono co-managing members. Gli allegati includono un accordo di deposito congiunto e una dichiarazione ai sensi dell'Item 8.

Inversores vinculados a Scoggin informan una pequeña participación pasiva en Scienture Holdings Inc. El informe revela que Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC y las personas Curtis Schenker y Craig Effron poseen cada uno, a título beneficiario, 150.000 acciones ordinarias de Scienture, lo que representa el 0,01% de las 16.131.180 acciones en circulación citadas en la presentación. Los declarantes indican que las participaciones no fueron adquiridas con el fin de influir en el control del emisor y detallan las relaciones entre las entidades: Scoggin GP LLC es el socio general (general partner) de Scoggin Management LP, que administra Scoggin International Fund Ltd., y los señores Schenker y Effron son co-managing members. Los anexos incluyen un acuerdo conjunto de presentación y una declaración conforme al Item 8.

스코긴(Scoggin) 계열 투자자들, 사이언튜어(Scienture) 홀딩스사의 소액 수동 지분 보고 신고서에 따르면 Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC 및 개인인 Curtis Schenker와 Craig Effron은 각각 Scienture 보통주 150,000주를 실질적으로 보유하고 있으며, 이는 신고서에 기재된 발행주식 16,131,180주의 0.01%에 해당합니다. 신고인들은 해당 보유지분이 발행회사의 지배권 행사 목적이 아니라는 점을 명시하고, 관계를 설명합니다: Scoggin GP LLC는 Scoggin Management LP의 제너럴 파트너이며, Scoggin Management LP는 Scoggin International Fund Ltd.를 운용하고, Schenker와 Effron은 공동 매니징 멤버입니다. 첨부서류로는 공동 제출 합의서와 Item 8 진술서가 포함되어 있습니다.

Des investisseurs affiliés à Scoggin déclarent une petite participation passive dans Scienture Holdings Inc. Le dépôt révèle que Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC et les personnes Curtis Schenker et Craig Effron détiennent chacun, à titre bénéficiaire, 150 000 actions ordinaires de Scienture, soit 0,01 % des 16 131 180 actions en circulation mentionnées dans le document. Les déclarants précisent que les positions n'ont pas été acquises dans le but d'influencer le contrôle de l'émetteur et exposent les relations entre les entités : Scoggin GP LLC est le general partner de Scoggin Management LP, qui gère Scoggin International Fund Ltd., et MM. Schenker et Effron sont co-managing members. Les annexes comprennent un accord de dépôt conjoint et une déclaration selon l'Item 8.

Scoggin-nahe Investoren melden eine kleine passive Beteiligung an Scienture Holdings Inc. Die Meldung weist aus, dass Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC sowie die Personen Curtis Schenker und Craig Effron jeweils wirtschaftlich 150.000 Aktien der Scienture-Stammaktien halten, was 0,01 % der in der Meldung angegebenen 16.131.180 ausstehenden Aktien entspricht. Die meldenden Personen geben an, dass die Beteiligungen nicht zum Zweck der Einflussnahme auf die Kontrolle des Emittenten erworben wurden, und erläutern die Beziehungen zwischen den Einheiten: Scoggin GP LLC ist der General Partner von Scoggin Management LP, welches Scoggin International Fund Ltd. verwaltet, und die Herren Schenker und Effron sind Co-Managing Members. Anlagen umfassen eine gemeinsame Einreichungsvereinbarung und eine Item-8-Erklärung.

Positive
  • Transparent disclosure of beneficial ownership by fund, management entities, and individuals
  • Clear statement that holdings are not intended to influence control, consistent with a passive 13G filing
  • Relationship mapping between entities and individuals is explicitly disclosed (general partner, investment manager, co-managing members)
Negative
  • None.

Insights

TL;DR: Minor passive position unlikely to affect shareholder control or company strategy.

The disclosed 150,000-share positions equal roughly 0.01% of outstanding common stock, which is immaterial relative to total shares outstanding and unlikely to move markets or shift governance outcomes. The filer categorizes the holdings as passive and certifies they were not acquired to influence control, consistent with a Schedule 13G filing. For investors this is a routine ownership disclosure from an investment manager and related entities; it provides transparency about ownership but does not signal a strategic stake or activist intent.

TL;DR: Ownership structure and filing form indicate compliance and no group control.

The filing clarifies the chain of control among the reporting persons and shows shared voting/dispositive arrangements for the two individual reporting persons, which is appropriately disclosed. The use of Schedule 13G and the certification that holdings are not meant to influence control align with passive investor treatment under SEC rules. There are no indications of coalition activity or control claims requiring a Schedule 13D, so governance impact is negligible based on the disclosed facts.

Investitori legati a Scoggin dichiarano una piccola partecipazione passiva in Scienture Holdings Inc. La comunicazione indica che Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC e gli individui Curtis Schenker e Craig Effron possiedono ciascuno beneficiariamente 150.000 azioni ordinarie di Scienture, pari allo 0,01% delle 16.131.180 azioni in circolazione citate nel deposito. I soggetti segnalanti precisano che le partecipazioni non sono state acquisite per influenzare il controllo dell'emittente e descrivono i rapporti tra le entità: Scoggin GP LLC è il general partner di Scoggin Management LP, che gestisce Scoggin International Fund Ltd., mentre i signori Schenker ed Effron sono co-managing members. Gli allegati includono un accordo di deposito congiunto e una dichiarazione ai sensi dell'Item 8.

Inversores vinculados a Scoggin informan una pequeña participación pasiva en Scienture Holdings Inc. El informe revela que Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC y las personas Curtis Schenker y Craig Effron poseen cada uno, a título beneficiario, 150.000 acciones ordinarias de Scienture, lo que representa el 0,01% de las 16.131.180 acciones en circulación citadas en la presentación. Los declarantes indican que las participaciones no fueron adquiridas con el fin de influir en el control del emisor y detallan las relaciones entre las entidades: Scoggin GP LLC es el socio general (general partner) de Scoggin Management LP, que administra Scoggin International Fund Ltd., y los señores Schenker y Effron son co-managing members. Los anexos incluyen un acuerdo conjunto de presentación y una declaración conforme al Item 8.

스코긴(Scoggin) 계열 투자자들, 사이언튜어(Scienture) 홀딩스사의 소액 수동 지분 보고 신고서에 따르면 Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC 및 개인인 Curtis Schenker와 Craig Effron은 각각 Scienture 보통주 150,000주를 실질적으로 보유하고 있으며, 이는 신고서에 기재된 발행주식 16,131,180주의 0.01%에 해당합니다. 신고인들은 해당 보유지분이 발행회사의 지배권 행사 목적이 아니라는 점을 명시하고, 관계를 설명합니다: Scoggin GP LLC는 Scoggin Management LP의 제너럴 파트너이며, Scoggin Management LP는 Scoggin International Fund Ltd.를 운용하고, Schenker와 Effron은 공동 매니징 멤버입니다. 첨부서류로는 공동 제출 합의서와 Item 8 진술서가 포함되어 있습니다.

Des investisseurs affiliés à Scoggin déclarent une petite participation passive dans Scienture Holdings Inc. Le dépôt révèle que Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC et les personnes Curtis Schenker et Craig Effron détiennent chacun, à titre bénéficiaire, 150 000 actions ordinaires de Scienture, soit 0,01 % des 16 131 180 actions en circulation mentionnées dans le document. Les déclarants précisent que les positions n'ont pas été acquises dans le but d'influencer le contrôle de l'émetteur et exposent les relations entre les entités : Scoggin GP LLC est le general partner de Scoggin Management LP, qui gère Scoggin International Fund Ltd., et MM. Schenker et Effron sont co-managing members. Les annexes comprennent un accord de dépôt conjoint et une déclaration selon l'Item 8.

Scoggin-nahe Investoren melden eine kleine passive Beteiligung an Scienture Holdings Inc. Die Meldung weist aus, dass Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC sowie die Personen Curtis Schenker und Craig Effron jeweils wirtschaftlich 150.000 Aktien der Scienture-Stammaktien halten, was 0,01 % der in der Meldung angegebenen 16.131.180 ausstehenden Aktien entspricht. Die meldenden Personen geben an, dass die Beteiligungen nicht zum Zweck der Einflussnahme auf die Kontrolle des Emittenten erworben wurden, und erläutern die Beziehungen zwischen den Einheiten: Scoggin GP LLC ist der General Partner von Scoggin Management LP, welches Scoggin International Fund Ltd. verwaltet, und die Herren Schenker und Effron sind Co-Managing Members. Anlagen umfassen eine gemeinsame Einreichungsvereinbarung und eine Item-8-Erklärung.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Comprised of shares of Common stock held by Scoggin International Fund Ltd. Curtis Schenker is a co-managing member of Scoggin GP LLC, which is the general partner of Scoggin Management LP, the investment manager of Scoggin International Fund Ltd. The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Comprised of shares of Common stock held by Scoggin International Fund Ltd. Craig Effron is a co-managing member of Scoggin GP LLC, which is the general partner of Scoggin Management LP, the investment manager of Scoggin International Fund Ltd. The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G



Scoggin International Fund Ltd.
Signature:/s/ Craig Effron
Name/Title:Craig Effron/Co-Managing Member
Date:08/20/2025
Scoggin Management LP
Signature:/s/ Craig Effron
Name/Title:Craig Effron/Co-Managing Member
Date:08/20/2025
Scoggin GP LLC
Signature:/s/ Craig Effron
Name/Title:Craig Effron/Co-Managing Member
Date:08/20/2025
Curtis Schenker
Signature:/s/ Curtis Schenker
Name/Title:Curtis Schenker
Date:08/20/2025
Craig Effron
Signature:/s/ Craig Effron
Name/Title:Craig Effron
Date:08/20/2025
Exhibit Information

Exhibit A. Joint Filing Agreement. Exhibit B. Item 8 Statement.

FAQ

What stake in Scienture Holdings (SCNX) did Scoggin report?

The reporting persons each beneficially own 150,000 shares, representing 0.01% of the 16,131,180 shares outstanding stated in the filing.

Which entities and individuals filed the Schedule 13G for SCNX?

Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC, Curtis Schenker, and Craig Effron are the reporting persons named in the filing.

Does the filing indicate intent to influence control of Scienture?

No. The filing includes a certification that the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

How are voting and dispositive powers allocated among the reporting persons?

Scoggin International Fund Ltd., Scoggin Management LP, and Scoggin GP LLC report sole voting and dispositive power over 150,000 shares; Curtis Schenker and Craig Effron report shared voting and dispositive power over 150,000 shares.

What exhibits accompany the Schedule 13G filing?

The filing lists Exhibit A: Joint Filing Agreement and Exhibit B: Item 8 Statement.
Scienture Holdings, Inc

NASDAQ:SCNX

SCNX Rankings

SCNX Latest News

SCNX Latest SEC Filings

SCNX Stock Data

17.26M
11.86M
22.08%
0.89%
0.29%
Pharmaceutical Retailers
Pharmaceutical Preparations
Link
United States
COMMACK